Novel Mixed NOP/Opioid Receptor Peptide Agonists | Journal of Medicinal Chemistry
IJMS | Free Full-Text | Syndecan-4 Is a Key Facilitator of the SARS-CoV-2 Delta Variant’s Superior Transmission
SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern | PNAS
Differential Interactions between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern | Journal of Chemical Theory and Computation
Viruses | Free Full-Text | Genomic Epidemiology of the SARS-CoV-2 Epidemic in Cyprus from November 2020 to October 2021: The Passage of Waves of Alpha and Delta Variants of Concern
Identification and differential usage of a host metalloproteinase entry pathway by SARS-CoV-2 Delta and Omicron - ScienceDirect
Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia | Nature Microbiology
Frontiers | Heteromerization Modulates mu Opioid Receptor Functional Properties in vivo
SARS-CoV-2 Beta and Delta variants trigger Fc effector function with increased cross-reactivity - ScienceDirect
The antigenicity of SARS-CoV-2 Delta variants aggregated 10 high-frequency mutations in RBD has not changed sufficiently to replace the current vaccine strain | Signal Transduction and Targeted Therapy
Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variants | Nature Communications
Frontiers | Nanobodies Protecting From Lethal SARS-CoV-2 Infection Target Receptor Binding Epitopes Preserved in Virus Variants Other Than Omicron
Vaccines | Free Full-Text | The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far
Interaction Analysis of the Spike Protein of Delta and Omicron Variants of SARS-CoV-2 with hACE2 and Eight Monoclonal Antibodies Using the Fragment Molecular Orbital Method | Journal of Chemical Information and Modeling
Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum | NEJM
Rapid assessment of SARS-CoV-2–evolved variants using virus-like particles | Science
Frontiers | Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies
Frontiers | SARS-CoV-2 Variants, Vaccines, and Host Immunity
The G protein-first activation mechanism of opioid receptors by Gi protein and agonists | QRB Discovery | Cambridge Core
Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern - eBioMedicine
Molecules | Free Full-Text | Severe Acute Respiratory Syndrome Coronavirus-2 Inactivation Activity of the Polyphenol-Rich Tea Leaf Extract with Concentrated Theaflavins and Other Virucidal Catechins
Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralization | PNAS
Functional expression of opioid receptors and other human GPCRs in yeast engineered to produce human sterols | Nature Communications
Emerging SARS-CoV-2 variants of concern and potential intervention approaches | Critical Care | Full Text
Pharmaceuticals | Free Full-Text | Opioid Analgesia and Opioid-Induced Adverse Effects: A Review
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion | Nature
Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies | Cell Discovery
